Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ZXH-4-130 TFA is a hetero-PROTAC (CRBN-VHL compound) that efficaciously and selectively mediates the degradation of CRBN. At a concentration of 10 nM in MM1.S cells, ZXH-4-130 TFA achieves approximately 80% degradation of CRBN [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | ZXH-4-130 TFA is a hetero-PROTAC (CRBN-VHL compound) that efficaciously and selectively mediates the degradation of CRBN. At a concentration of 10 nM in MM1.S cells, ZXH-4-130 TFA achieves approximately 80% degradation of CRBN [1]. |
In vitro | ZXH-4-130 TFA at a concentration of 100 nM and pre-treatment for 2 hours significantly inhibited the cytotoxic effects of pomalidomide (1 μM) when cells were subsequently treated for 96 hours, displaying a statistically significant protective effect [1]. Additionally, a pre-treatment with ZXH-4-130 TFA at 50 nM was able to rescue the degradation of GSPT1 in MM1.S cells induced by CC-885 [1]. Furthermore, ZXH-4-130 TFA (100 nM; pre-treated for 2 hours, followed by treatment with THAL-SNS-032 for 6 hours) nearly completely induced the degradation of CRBN, whereas THAL-SNS-032 only partially inhibited CDK9 activity [1]. |
Molecular Weight | 985.08 |
Formula | C48H59F3N6O11S |
CAS No. | 2711006-67-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ZXH-4-130 TFA 2711006-67-4 PROTAC PROTACs inhibitor inhibit